Choi Jung

CIK 00016501262 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001650126

Recent Transactions

50 trades

Purchase
Annexon, Inc.$ANNX
Common Stock
2025-12-01$4.19/sh+33,000→ 33,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-06-05+55,000→ 55,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2024-06-05+44,000→ 44,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2023-06-08+24,000→ 24,000 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−32,098→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−226,672→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−40,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−15,460→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−42,400→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−13,814→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,739→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−28,628→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−1→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−1→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,454→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−36,225→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,125→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−35,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−9,060→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−25,000→ 0 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-29−73,855→ 226,672 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$3.40/sh+2,674→ 300,527 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$3.40/sh+2,674→ 297,853 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$65.82/sh+2,275→ 220,215 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$16.40/sh+16,902→ 217,940 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−2,275→ 36,225 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$3.40/sh+74,964→ 295,179 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−2,674→ 1 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−2,674→ 1 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−74,964→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−16,902→ 32,098 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,208→ 15,460 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,208→ 202,899 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−1,861→ 201,038 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,763→ 13,814 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,763→ 200,691 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,125→ 3,125 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01+6,145→ 200,054 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,020→ 9,060 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01$32.40/sh−2,126→ 197,928 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2022-06-09+24,000→ 24,000 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01−2,763→ 16,577 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01+2,763→ 192,330 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01$29.87/sh−956→ 191,374 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
2022-03-01+28,628→ 28,628 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-02-01−2,875→ 0 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-02-01$29.33/sh−3,340→ 189,567 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-02-01+9,020→ 192,907 total

Companies

Recent Filings

Address

C/O ANNEXON, INC. 1400 SIERRA POINT PKWY, BLDG C, STE 200

BRISBANE, CA, 94005

View on SEC.gov